| 0 (0%) | 04-19 12:29 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.3 | 1-year : | 2.68 |
| Resists | First : | 1.97 | Second : | 2.3 |
| Pivot price | 1.65  |
|||
| Supports | First : | 1.35 | Second : | 0.97 |
| MAs | MA(5) : | 1.75  |
MA(20) : | 1.5 |
| MA(100) : | 1.11 |
MA(250) : | 1.1 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 77.6 |
D(3) : | 77.6 |
| RSI | RSI(14): 65.8 |
|||
| 52-week | High : | 1.97 | Low : | 0.69 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SGRP ] has closed below upper band by 41.3%. Bollinger Bands are 262.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 13 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.85 - 1.86 | 1.86 - 1.86 |
| Low: | 1.71 - 1.72 | 1.72 - 1.73 |
| Close: | 1.76 - 1.77 | 1.77 - 1.78 |
Wed, 01 Dec 2021
OKYO Pharma Limited: Directorate Change - GlobeNewswire
Wed, 06 Mar 2019
Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. - PR Newswire
Wed, 19 Dec 2018
End Of The Line For Synergy Pharmaceuticals (NASDAQ:SGYP-OLD-DEFUNCT-16944) - Seeking Alpha
Wed, 12 Dec 2018
Synergy Pharmaceuticals Bankruptcy: SGYP Stock Plummets on Filing - Yahoo Finance
Thu, 25 Oct 2018
Synergy Pharmaceuticals Provides Business Update - Business Wire
Fri, 19 Oct 2018
Ironwood Rides on Linzess' Progress, Stalls Lenisurad Drugs - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 24 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 59.4 (%) |
| Held by Institutions | 9.1 (%) |
| Shares Short | 9 (K) |
| Shares Short P.Month | 4 (K) |
| EPS | 0.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.21 |
| Profit Margin | 1.4 % |
| Operating Margin | 4.2 % |
| Return on Assets (ttm) | 7 % |
| Return on Equity (ttm) | 12.1 % |
| Qtrly Rev. Growth | 0.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 10.84 |
| EBITDA (p.s.) | 0.46 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 7 (M) |
| Levered Free Cash Flow | 7 (M) |
| PE Ratio | 10.87 |
| PEG Ratio | 0 |
| Price to Book value | 1.43 |
| Price to Sales | 0.16 |
| Price to Cash Flow | 6.17 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|